Step Therapy Implementation
- 1Identify target conditions: Conditions with multiple therapeutic options at different cost levels
- 2Define step sequence: Evidence-based sequence from lowest-cost to highest-cost options
- 3Define step duration: How long must the patient try the first-line drug before advancing?
- 4Define exceptions: Contraindications, prior treatment failure, clinical urgency
- 5Communicate to physicians: Clear communication of step therapy requirements
- 6Monitor compliance: Verify that patients actually try first-line drugs before advancing
Exception Management
Step therapy exceptions are essential for clinical appropriateness. Common exceptions: (1) prior treatment failure — patient has already tried and failed the first-line drug; (2) contraindication — first-line drug is contraindicated for the patient; (3) clinical urgency — patient needs the higher-cost drug immediately; and (4) physician attestation — physician documents medical necessity for the higher-cost drug.
Step Therapy Compliance
IQ Insight
Step therapy compliance — ensuring patients actually try first-line drugs before advancing — is essential for program effectiveness. Without compliance monitoring, patients may receive exceptions without actually trying first-line drugs. Retrospective claims analysis can identify patients who received step therapy exceptions without documented first-line drug trials.